Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cohen

Showing results (141-150 of 5,277) with videos related to

Pageof 528
Sort By:
Scientific American|April 1, 1988
The self, the world and autoimmunityI R Cohen
Nursing|September 1, 1989
Why two professionals should interpret ordersM R Cohen
World Journal of Clinical Cases|December 31, 2016
Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentationPhilip R Cohen
Cureus|February 14, 2017
Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with CapecitabinePhilip R Cohen
Nursing|October 18, 2003
Oral vs. i.v. hydromorphone. Add a measure of cautionMichael R Cohen
Journal of the American Academy of Dermatology|August 1, 1992
Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndromeP R Cohen
Nursing|December 5, 2003
Patient controlled analgesia. Pushing for safe pain reliefMichael R Cohen
The Israel Medical Association Journal : IMAJ|May 21, 2004
Thoughts on the pathogenesis of type 1 diabetes and on the arrest of autoimmune beta-cell destruction by peptide p277 vaccinationIrun R Cohen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 15, 1995
Drug product characteristics that foster drug-use-system errorsM R Cohen
Chemical Immunology|January 1, 1995
Treatment of autoimmune disease: to activate or to deactivate?I R Cohen
Pageof 528

Showing results (141-150 of 5,277) with videos related to

Sort By:
Pageof 528
Scientific American|April 1, 1988
The self, the world and autoimmunityI R Cohen
Nursing|September 1, 1989
Why two professionals should interpret ordersM R Cohen
World Journal of Clinical Cases|December 31, 2016
Paclitaxel-associated reticulate hyperpigmentation: Report and review of chemotherapy-induced reticulate hyperpigmentationPhilip R Cohen
Cureus|February 14, 2017
Capecitabine-Associated Loss of Fingerprints: Report of Capecitabine-Induced Adermatoglyphia in Two Women with Breast Cancer and Review of Acquired Dermatoglyphic Absence in Oncology Patients Treated with CapecitabinePhilip R Cohen
Nursing|October 18, 2003
Oral vs. i.v. hydromorphone. Add a measure of cautionMichael R Cohen
Journal of the American Academy of Dermatology|August 1, 1992
Sebaceous carcinomas of the ocular adnexa and the Muir-Torre syndromeP R Cohen
Nursing|December 5, 2003
Patient controlled analgesia. Pushing for safe pain reliefMichael R Cohen
The Israel Medical Association Journal : IMAJ|May 21, 2004
Thoughts on the pathogenesis of type 1 diabetes and on the arrest of autoimmune beta-cell destruction by peptide p277 vaccinationIrun R Cohen
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 15, 1995
Drug product characteristics that foster drug-use-system errorsM R Cohen
Chemical Immunology|January 1, 1995
Treatment of autoimmune disease: to activate or to deactivate?I R Cohen
Pageof 528